Quantification of contrast agent materials using a new image- domain multi material decomposition algorithm based on dual energy CT

por Mirzaei, Fazel, Faghihi, Reza
Publicado 2019

Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study

por Marchesini, Gessica, Nadali, Gianpaolo, Facchinelli, Davide, Candoni, Anna, Cattaneo, Chiara, Laurenti, Luca, Fanci, Rosa, Farina, Francesca, Lessi, Federica, Visentin, Andrea, Marchesi, Francesco, Prezioso, Lucia, Spolzino, Angelica, Tisi, Maria Chiara, Trastulli, Fabio, Picardi, Marika, Verga, Luisa, Dargenio, Michelina, Busca, Alessandro, Pagano, Livio
Publicado 2020

Illusory social agents within and beyond voices: A computational linguistics analysis of the experience of psychosis

por Shiel, Lisha, Demjén, Zsófia, Bell, Vaughan
Publicado 2021

A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides

por Peric, Mihaela, Pešić, Dijana, Alihodžić, Sulejman, Fajdetić, Andrea, Herreros, Esperanza, Gamo, Francisco Javier, Angulo‐Barturen, Iñigo, Jiménez‐Díaz, María Belén, Ferrer‐Bazaga, Santiago, Martínez, María S., Gargallo‐Viola, Domingo, Mathis, Amanda, Kessler, Albane, Banjanac, Mihailo, Padovan, Jasna, Bencetić Mihaljević, Vlatka, Munic Kos, Vesna, Bukvić, Mirjana, Eraković Haber, Vesna, Spaventi, Radan
Publicado 2020

Antibody response and intra‐host viral evolution after plasma therapy in COVID‐19 patients pre‐exposed or not to B‐cell‐depleting agents

por Gachoud, David, Pillonel, Trestan, Tsilimidos, Gerasimos, Battolla, Dunia, Dumas, Dominique, Opota, Onya, Fontana, Stefano, Vollenweider, Peter, Manuel, Oriol, Greub, Gilbert, Bertelli, Claire, Rufer, Nathalie
Publicado 2022

Disease-modifying agents in osteoarthritis: where are we now and what does the future hold?

por Makaram, Navnit S., Simpson, A. H. R. W.
Publicado 2023

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis

por Schäfer, Martin, Meißner, Yvette, Kekow, Jörn, Berger, Sylvia, Remstedt, Sven, Manger, Bernhard, Listing, Joachim, Strangfeld, Anja, Zink, Angela
Publicado 2020

Novel bulking agent for faecal incontinence

por Ratto, C, Parello, A, Donisi, L, Litta, F, De Simone, V, Spazzafumo, L, Giordano, P
Publicado 2011

Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies

por Norris, Stephen, Ramael, Steven, Ikushima, Ippei, Haazen, Wouter, Harada, Akiko, Moschetti, Viktoria, Imazu, Susumu, Reilly, Paul A., Lang, Benjamin, Stangier, Joachim, Glund, Stephan
Publicado 2017

Detection and Assessment of the Distribution of Infectious Agents in Juvenile Fraser River Sockeye Salmon, Canada, in 2012 and 2013

por Nekouei, Omid, Vanderstichel, Raphael, Ming, Tobi, Kaukinen, Karia H., Thakur, Krishna, Tabata, Amy, Laurin, Emilie, Tucker, Strahan, Beacham, Terry D., Miller, Kristina M.
Publicado 2018

Long-term Histopathologic Follow-up of a Spherical Embolic Agent; Observation of the Transvascular Migration of HepaSphere(TM)

por Kennoki, Norifumi, Saguchi, Toru, Sano, Toru, Takara, Yuki, Moriya, Tomohisa, Shirota, Natsuhiko, Otaka, Jun, Chiba, Naokazu, Kawachi, Shigeyuki, Serizawa, Hiromi, Koizumi, Kiyoshi, Tokuuye, Koichi
Publicado 2019

Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate‐to‐severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results...

por Kabashima, K., Matsumura, T., Komazaki, H., Kawashima, M.
Publicado 2021

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis()

por Denning, David W., Marr, Kieren A., Lau, Wendi M., Facklam, David P., Ratanatharathorn, Voravit, Becker, Cornelia, Ullmann, Andrew J., Seibel, Nita L., Flynn, Patricia M., van Burik, Jo-Anne H., Buell, Donald N., Patterson, Thomas F.
Publicado 2006

Harnessing inflammation resolving‐based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID‐19?

por Sousa, Lirlândia P., Pinho, Vanessa, Teixeira, Mauro M.
Publicado 2020

Quantitative Estimation of Naproxen in Tablets Using Ibuprofen Sodium as Hydrotropic Agent

por Maheshwari, R. K., Wanare, G., Chahar, Nitika, Joshi, Prajakta, Nayak, Nishi
Publicado 2009

The Impact of “Omic” and Imaging Technologies on Assessing the Host Immune Response to Biodefence Agents

por Tree, Julia A., Flick-Smith, Helen, Elmore, Michael J., Rowland, Caroline A.
Publicado 2014

The role of chemotherapy and new targeted agents in the management of primary prostate cancer

por Kumar, Sanjeev Srinivas, Pacey, Simon
Publicado 2016

A registry study of relapsed or refractory multiple myeloma pre‐exposed to three or more prior therapies including a proteasome inhibitor, an immunomodulatory agent and CD38‐target...

por Elsada, Ahmed, Zalin‐Miller, Amy, Knott, Craig, Caravotas, Leonidas
Publicado 2021

Treating exposure to chemical warfare agents: implications for health care providers and community emergency planning.

por Munro, N B, Watson, A P, Ambrose, K R, Griffin, G D
Publicado 1990

A Review on Coordination Properties of Thiol-Containing Chelating Agents Towards Mercury, Cadmium, and Lead

por Bjørklund, Geir, Crisponi, Guido, Nurchi, Valeria Marina, Cappai, Rosita, Buha Djordjevic, Aleksandra, Aaseth, Jan
Publicado 2019